The report also covers a detailed description of the drug ... Acquired Hemophilia A Key players such as - Belief Biomed, ISU ABXIS, TiumBio, Be Biopharma, Regeneron Pharmaceuticals, Pfizer ...

Jivi antihemophilic factor is now approved for children aged 7-12 with hemophilia A, expanding its previous approval for older patients. Hemophilia A is more common than hemophilia B, with early ...

In May, the FDA granted significant drug approvals across various therapeutic areas, marking notable progress in expanding treatment options for patients.

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia ... in patients aged 12 and older and is the first drug in the anti-TFPI class to be approved in ...

May 18 (UPI) --The U.S. Food and Drug Administration ... Ursula von der Leyen's Pfizer texts must be released to New York Times Novavax's updated COVID-19 vaccine gets FDA approval Shingles ...

Not intended for media outside the U.S. WHIPPANY, N.J., May 19, 2025--(BUSINESS WIRE)--Bayer announced that the U.S. Food and Drug ... hemophilia community. Jivi was first granted approval by the ...

WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID ... Vaccines made by Novavax’s competitors Pfizer and Moderna already are fully licensed ...

May 15 (Reuters) - The U.S. Food and Drug Administration has approved ... Axsome Therapeutics' <AXSM.O> recently approved Symbravo and Pfizer's (PFE.N), opens new tab Nurtec ODT.